Substance Use during Pregnancy: A Retrospective Multicenter Clinical Report from Four Italian Centers
Clinical Neuropsychopharmacology and Addiction · 2026
DOI: 10.53941/cna.2026.100013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Neuropsychopharmacology and Addiction, 2026. Verfasst von Antonio Inserra und 12 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Progetti di Ricerca di Rilevante Interesse Nazionale – 2022.
Abstract (Originalsprache)
Background
Rising substance use during pregnancy is a major global health concern associated with adverse maternal and neonatal outcomes. Despite growing international literature, Italian real-world multicenter data remain limited.
Methods
We conducted a retrospective descriptive analysis of 31 women who reported substance use during a current or previous pregnancy across four Italian clinical centers using data collected between January 2024 and October 2025. Each participant contributed one index pregnancy to the maternal and neonatal outcome analysis. The 54 pregnancies recorded for the overall cohort represented cumulative obstetric history and were not treated as independent observations. Collected variables included type of substance, maintenance therapy, psychiatric diagnosis, infectious serology, neonatal outcomes, obstetric history, and partner relationship quality.
Results
Opioid use (alone or in combination) was present in 77.4% of participants, cocaine/crack in 54.8%, and cannabis in 22.6%. Polysubstance use was common. Prematurity occurred in 13 of 31 index pregnancies (41.9%), and neonatal abstinence syndrome was documented in 10 of 31 index pregnancies (32.3%), all of which were opioid-exposed. Human immunodeficiency virus (HIV) positivity was present in 29.0% of participants and Hepatitis C Virus in 16.1%, exclusively among opioid-exposed women. Conflictual or unstable partner relationships were reported in 45.2% of participants.
Conclusions
In this small, selected Italian multicenter clinical sample, substance use during pregnancy was heterogeneous and frequently associated with medical, psychiatric, and psychosocial vulnerability. Opioid exposure predominated, and all cases of neonatal abstinence syndrome occurred among opioid-exposed index pregnancies, while cocaine/crack and cannabis use were also frequently documented. Given the descriptive design and small sample size, these findings should not be interpreted as population-level prevalence estimates or as evidence of causal relationships between individual substances and pregnancy outcomes.
Förderung
- Progetti di Ricerca di Rilevante Interesse Nazionale – 2022
Zitieren
APA
Inserra, A., Carlo, F. D., Micale, V., D'Addario, C., Cesare, A. D., Mayer, R., Marasca, G., Francesconi, G., Volgare, R., Miotti, L., Volpe, U., Pettorruso, M., & Martinotti, G. (2026). Substance Use during Pregnancy: A Retrospective Multicenter Clinical Report from Four Italian Centers. Clinical Neuropsychopharmacology and Addiction. https://doi.org/10.53941/cna.2026.100013
Vancouver
Inserra A, Carlo FD, Micale V, D'Addario C, Cesare AD, Mayer R, et al. Substance Use during Pregnancy: A Retrospective Multicenter Clinical Report from Four Italian Centers. Clinical Neuropsychopharmacology and Addiction. 2026. doi:10.53941/cna.2026.100013
BibTeX
@article{Inserra2026,
author = {Inserra, Antonio and Carlo, Francesco Di and Micale, Vincenzo and D'Addario, Claudio and Cesare, Andrea Di and Mayer, Roberto and Marasca, Giulio and Francesconi, Giulia and Volgare, Rosa and Miotti, Livia and Volpe, Umberto and Pettorruso, Mauro and Martinotti, Giovanni},
title = {Substance Use during Pregnancy: A Retrospective Multicenter Clinical Report from Four Italian Centers},
journal = {Clinical Neuropsychopharmacology and Addiction},
year = {2026},
doi = {10.53941/cna.2026.100013}
}
EUVIMED